Influence of the inflammasome complex on psychiatric disorders: clinical and preclinical studies

References

• Chisholm D, Sweeny K, Sheehan P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016 May;3(5):415–424.
   PubMed Web of Science ®Google Scholar
• Uher R, Zwicker A. Etiology in psychiatry: embracing the reality of poly-gene-environmental causation of mental illness. World Psychiatry. 2017 Jun;16(2):121–129.
   PubMed Web of Science ®Google Scholar
• Bennett FC, Molofsky AV. The immune system and psychiatric disease: a basic science perspective. Clin Exp Immunol. 2019 Sep;197(3):294–307.
   PubMed Web of Science ®Google Scholar
• Tang CZ, Zhang DF, Yang JT, et al. Overexpression of microRNA-301b accelerates hippocampal microglia activation and cognitive impairment in mice with depressive-like behavior through the NF-kappaB signaling pathway. Cell Death Dis. 2019 Apr 8;10(4):316.
   PubMedGoogle Scholar
• Mondelli V, Vernon AC, Turkheimer F, et al. Brain microglia in psychiatric disorders. Lancet Psychiatry. 2017 Jul;4(7):563–572.
   PubMed Web of Science ®Google Scholar
• Najjar S, Pearlman DM, Alper K, et al. Neuroinflammation and psychiatric illness. J Neuroinflammation. 2013 Apr;1(10):43.
   Google Scholar
• Bauer ME, Teixeira AL. Neuroinflammation in mood disorders: role of regulatory immune cells. Neuroimmunomodulation. 2021;28(3):99–107.
   PubMed Web of Science ®Google Scholar
• Schnieder TP, Trencevska I, Rosoklija G, et al. Microglia of prefrontal white matter in suicide. J Neuropathol Exp Neurol. 2014 Sep;73(9):880–890.
   PubMed Web of Science ®Google Scholar
• Beumer W, Gibney SM, Drexhage RC, et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol. 2012 Nov;92(5):959–975.
   PubMed Web of Science ®Google Scholar
• Kang E, Wen Z, Song H, et al. Adult neurogenesis and psychiatric disorders. Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a019026.
   PubMed Web of Science ®Google Scholar
• Duman RS. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci. 2009;11(3):239–255.
   PubMedGoogle Scholar
• Zheng D, Liwinski T, Elinav E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 2020;6:36.
   PubMed Web of Science ®Google Scholar
• Michopoulos V, Powers A, Gillespie CF, et al. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017 Jan;42(1):254–270.
   PubMed Web of Science ®Google Scholar
• Weber MD, Frank MG, Tracey KJ, et al. Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome. J Neurosci. 2015 Jan 7;35(1):316–324.
   PubMed Web of Science ®Google Scholar
• Iwata M, Ota KT, Duman RS. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun. 2013 Jul;31:105–114.
   PubMed Web of Science ®Google Scholar
• Feng X, Zhao Y, Yang T, et al. Glucocorticoid-driven NLRP3 inflammasome activation in hippocampal microglia mediates chronic stress-induced depressive-like behaviors. Front Mol Neurosci. 2019;12:210.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Zhai Y, Liang S, et al. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun. 2013;4(1):1611.
   PubMedGoogle Scholar
• Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016 Jul;16(7):407–420.
   PubMed Web of Science ®Google Scholar
• Li Y, Huang H, Liu B, et al. Inflammasomes as therapeutic targets in human diseases. Signal Transduct Target Ther. 2021 Jul 2;6(1):247.
   PubMed Web of Science ®Google Scholar
• Cheon SY, Kim J, Kim SY, et al. Inflammasome and cognitive symptoms in human diseases: biological evidence from experimental research. Int J Mol Sci. 2020 Feb 7;21(3):3.
   Web of Science ®Google Scholar
• Fann DY, Lim YA, Cheng YL, et al. Evidence that NF-kappaB and MAPK signaling promotes nlrp inflammasome activation in neurons following ischemic stroke. Mol Neurobiol. 2018 Feb;55(2):1082–1096.
   PubMed Web of Science ®Google Scholar
• Wang W, Hu D, Wu C, et al. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog. 2020 Mar;16(3):e1008335.
   PubMed Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019 Aug;19(8):477–489.
   PubMed Web of Science ®Google Scholar
• Kursun O, Yemisci M, van Den Maagdenberg A, et al. Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain. 2021 Jun 10;22(1):55.
   PubMed Web of Science ®Google Scholar
• Heneka MT, McManus RM, Latz E. Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci. 2018 Oct;19(10):610–621.
   PubMed Web of Science ®Google Scholar
• Conforti-Andreoni C, Ricciardi-Castagnoli P, Mortellaro A. The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond. Cell Mol Immunol. 2011 Mar;8(2):135–145.
   PubMed Web of Science ®Google Scholar
• Heneka MT, McManus RM, Latz E. Author correction: inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci. 2019 Mar;20(3):187.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Stringaris A, Wolpert M. Treatment outcomes for depression: challenges and opportunities. Lancet Psychiatry. 2020 Nov;7(11):925–927.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Mann JJ. Depression. Lancet. 2018 Nov 24;392(10161):2299–2312.
   PubMed Web of Science ®Google Scholar
• Zhuo C, Li G, Lin X, et al. The rise and fall of MRI studies in major depressive disorder. Transl Psychiatry. 2019 Dec 9;9(1):335.
   PubMedGoogle Scholar
• Kaufmann FN, Costa AP, Ghisleni G, et al. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun. 2017 Aug;64:367–383.
   PubMed Web of Science ®Google Scholar
• Botteron KN, Raichle ME, Drevets WC, et al. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry. 2002 Feb 15;51(4):342–344.
   PubMed Web of Science ®Google Scholar
• Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004 Nov;161(11):1957–1966.
   PubMed Web of Science ®Google Scholar
• Verduijn J, Milaneschi Y, Schoevers RA, et al. Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression. Transl Psychiatry. 2015 Sep;5(9):e649.
   PubMedGoogle Scholar
• Li Z, Ruan M, Chen J, et al. Major depressive disorder: advances in neuroscience research and translational applications. Neurosci Bull. 2021 Jun;37(6):863–880.
   PubMed Web of Science ®Google Scholar
• Maes M, Van der Planken M, Stevens WJ, et al. Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. J Psychiatr Res. 1992 Apr;26(2):125–134.
   PubMed Web of Science ®Google Scholar
• Zou W, Feng R, Yang Y. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naive patients with major depression. PLoS One. 2018;13(6):e0197267.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008 Jan;9(1):46–56.
   PubMed Web of Science ®Google Scholar
• Felger JC, Li Z, Haroon E, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2016 Oct;21(10):1358–1365.
   PubMed Web of Science ®Google Scholar
• Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry. 2011 Jul;16(7):751–762.
   PubMed Web of Science ®Google Scholar
• Yu YW, Chen TJ, Hong CJ, et al. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology. 2003 Jun;28(6):1182–1185.
   PubMed Web of Science ®Google Scholar
• Thomas AJ, Davis S, Morris C, et al. Increase in interleukin-1beta in late-life depression. Am J Psychiatry. 2005 Jan;162(1):175–177.
   PubMed Web of Science ®Google Scholar
• Maes M, Bosmans E, Meltzer HY, et al. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry. 1993 Aug;150(8):1189–1193.
   PubMed Web of Science ®Google Scholar
• Levine J, Barak Y, Chengappa KN, et al. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology. 1999 Nov;40(4):171–176.
   PubMed Web of Science ®Google Scholar
• Miller ES, Sakowicz A, Roy A, et al. Plasma and cerebrospinal fluid inflammatory cytokines in perinatal depression. Am J Obstet Gynecol. 2019 Mar;220(3):271e1–271 e10.
   Web of Science ®Google Scholar
• Merendino RA, Di Rosa AE, Di Pasquale G, et al. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm. 2002 Aug;11(4):265–267.
   PubMed Web of Science ®Google Scholar
• Prossin AR, Koch AE, Campbell PL, et al. Association of plasma interleukin-18 levels with emotion regulation and mu-opioid neurotransmitter function in major depression and healthy volunteers. Biol Psychiatry. 2011 Apr 15;69(8):808–812.
   PubMed Web of Science ®Google Scholar
• Alcocer-Gomez E, de Miguel M, Casas-Barquero N, et al. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun. 2014 Feb;36:111–117.
   PubMed Web of Science ®Google Scholar
• Taene A, Khalili-Tanha G, Esmaeili A, et al. The association of major depressive disorder with activation of nlrp3 inflammasome, lipid peroxidation, and total antioxidant capacity. J Mol Neurosci. 2020 Jan;70(1):65–70.
   PubMed Web of Science ®Google Scholar
• Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):751–756.
   PubMed Web of Science ®Google Scholar
• Pan Y, Chen XY, Zhang QY, et al. Microglial NLRP3 inflammasome activation mediates IL-1beta-related inflammation in prefrontal cortex of depressive rats. Brain Behav Immun. 2014 Oct;41:90–100.
   PubMed Web of Science ®Google Scholar
• Song AQ, Gao B, Fan JJ, et al. NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice. J Neuroinflammation. 2020 Jun 8;17(1):178.
   PubMed Web of Science ®Google Scholar
• Tynan RJ, Naicker S, Hinwood M, et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun. 2010 Oct;24(7):1058–1068.
   PubMed Web of Science ®Google Scholar
• Wong ML, Inserra A, Lewis MD, et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 2016 Jun;21(6):797–805.
   PubMed Web of Science ®Google Scholar
• Penninx BW, Pine DS, Holmes EA, et al. Anxiety disorders. Lancet. 2021 Mar 6;397(10277):914–927.
   PubMed Web of Science ®Google Scholar
• Tyrer P, Baldwin D. Generalised anxiety disorder. Lancet. 2006 Dec 16;368(9553):2156–2166.
   PubMed Web of Science ®Google Scholar
• Craske MG, Stein MB. Anxiety. Lancet. 2016 Dec 17;388(10063):3048–3059.
   PubMed Web of Science ®Google Scholar
• Robinson OJ, Krimsky M, Lieberman L, et al. Towards a mechanistic understanding of pathological anxiety: the dorsal medial prefrontal-amygdala ‘aversive amplification’ circuit in unmedicated generalized and social anxiety disorders. Lancet Psychiatry. 2014 Sep 1;1(4):294–302.
   PubMedGoogle Scholar
• Holzschneider K, Mulert C. Neuroimaging in anxiety disorders. Dialogues Clin Neurosci. 2011;13(4):453–461.
   PubMedGoogle Scholar
• Mah L, Szabuniewicz C, Fiocco AJ. Can anxiety damage the brain? Curr Opin Psychiatry. 2016 Jan;29(1):56–63.
   PubMed Web of Science ®Google Scholar
• Pine DS. Pathophysiology of childhood anxiety disorders. Biol Psychiatry. 1999 Dec 1;46(11):1555–1566.
   PubMed Web of Science ®Google Scholar
• Patriquin MA, Mathew SJ. The neurobiological mechanisms of generalized anxiety disorder and chronic stress. Chronic Stress (Thousand Oaks). 2017 Jan-Dec;1. https://doi.org/10.1177/2470547017703993.
   Google Scholar
• Bishir M, Bhat A, Essa MM, et al. Sleep deprivation and neurological disorders. Biomed Res Int. 2020;2020:5764017.
   PubMed Web of Science ®Google Scholar
• Papadimitriou GN, Linkowski P. Sleep disturbance in anxiety disorders. Int Rev Psychiatry. 2005 Aug;17(4):229–236.
   PubMed Web of Science ®Google Scholar
• Richards A, Kanady JC, Neylan TC. Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms. Neuropsychopharmacology. 2020 Jan;45(1):55–73.
   PubMed Web of Science ®Google Scholar
• McMakin DL, Alfano CA. Sleep and anxiety in late childhood and early adolescence. Curr Opin Psychiatry. 2015 Nov;28(6):483–489.
   PubMed Web of Science ®Google Scholar
• Staner L. Sleep and anxiety disorders. Dialogues Clin Neurosci. 2003 Sep;5(3):249–258.
   PubMedGoogle Scholar
• Brenes GA, Miller ME, Stanley MA, et al. Insomnia in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry. 2009 Jun;17(6):465–472.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu X, Liang W, et al. Objective short sleep duration is related to the peripheral inflammasome dysregulation in patients with chronic insomnia. Nat Sci Sleep. 2020;12:759–766.
   PubMed Web of Science ®Google Scholar
• Felger JC. Imaging the role of inflammation in mood and anxiety-related disorders. Curr Neuropharmacol. 2018;16(5):533–558.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Eisenberger NI, Olmstead R, et al. Preexisting mild sleep disturbance as a vulnerability factor for inflammation-induced depressed mood: a human experimental study. Transl Psychiatry. 2016 Mar;6(3):e750.
   PubMedGoogle Scholar
• Hou R, Garner M, Holmes C, et al. Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun. 2017 May;62:212–218.
   PubMed Web of Science ®Google Scholar
• Vogelzangs N, Beekman AT, de Jonge P, et al. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013 Apr;3(4):e249.
   PubMedGoogle Scholar
• Hoge EA, Brandstetter K, Moshier S, et al. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009;26(5):447–455.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Bellodi L, Perna G, et al. Plasma interleukin-1 beta concentrations in panic disorder. Psychiatry Res. 1994 Nov;54(2):135–142.
   PubMed Web of Science ®Google Scholar
• Kovacs D, Eszlari N, Petschner P, et al. Effects of IL1B single nucleotide polymorphisms on depressive and anxiety symptoms are determined by severity and type of life stress. Brain Behav Immun. 2016 Aug;56:96–104.
   PubMed Web of Science ®Google Scholar
• Rooney S, Sah A, Unger MS, et al. Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline. Transl Psychiatry. 2020 Jul 30;10(1):256.
   PubMed Web of Science ®Google Scholar
• Munshi S, Loh MK, Ferrara N, et al. Repeated stress induces a pro-inflammatory state, increases amygdala neuronal and microglial activation, and causes anxiety in adult male rats. Brain Behav Immun. 2020 Feb;84:180–199.
   PubMed Web of Science ®Google Scholar
• Wohleb ES, Patterson JM, Sharma V, et al. Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior. J Neurosci. 2014 Feb 12;34(7):2583–2591.
   PubMed Web of Science ®Google Scholar
• Rossi S, Sacchetti L, Napolitano F, et al. Interleukin-1beta causes anxiety by interacting with the endocannabinoid system. J Neurosci. 2012 Oct 3;32(40):13896–13905.
   PubMed Web of Science ®Google Scholar
• Li M, Li C, Yu H, et al. Lentivirus-mediated interleukin-1beta (IL-1beta) knock-down in the hippocampus alleviates lipopolysaccharide (LPS)-induced memory deficits and anxiety- and depression-like behaviors in mice. J Neuroinflammation. 2017 Sep 20;14(1):190.
   PubMedGoogle Scholar
• Dong Y, Li S, Lu Y, et al. Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice. J Neuroinflammation. 2020 Jul 7;17(1):205.
   PubMed Web of Science ®Google Scholar
• Sekiyama A, Ueda H, Kashiwamura S, et al. A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation. Immunity. 2005 Jun;22(6):669–677.
   PubMed Web of Science ®Google Scholar
• Smith C, Trageser KJ, Wu H, et al. Anxiolytic effects of NLRP3 inflammasome inhibition in a model of chronic sleep deprivation. Transl Psychiatry. 2021 Jan 14;11(1):52.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Berk M, Brietzke E, et al. Bipolar disorders. Lancet. 2020 Dec 5;396(10265):1841–1856.
   PubMed Web of Science ®Google Scholar
• Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016 Apr 9;387(10027):1561–1572.
   PubMed Web of Science ®Google Scholar
• Clark L, Sahakian BJ. Cognitive neuroscience and brain imaging in bipolar disorder. Dialogues Clin Neurosci. 2008;10(2):153–163.
   PubMedGoogle Scholar
• Brambilla P, Hatch JP, Soares JC. Limbic changes identified by imaging in bipolar patients. Curr Psychiatry Rep. 2008 Dec;10(6):505–509.
   PubMedGoogle Scholar
• Vieta E, Berk M, Schulze TG, et al. Bipolar disorders. Nat Rev Dis Primers. 2018 Mar;4(1):18008.
   PubMedGoogle Scholar
• Magioncalda P, and Martino M. A unified model of the pathophysiology of bipolar disorder. Mol Psychiatry. 2021 Apr;15 doi:https://doi.org/10.1038/s41380-021-01091-4.
   Google Scholar
• Giridharan VV, Sayana P, Pinjari OF, et al. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review. Mol Psychiatry. 2020 Jan;25(1):94–113.
   PubMed Web of Science ®Google Scholar
• Sayana P, Colpo GD, Simoes LR, et al. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res. 2017 Sep;92:160–182.
   PubMed Web of Science ®Google Scholar
• Fiedorowicz JG, Prossin AR, Johnson CP, et al. Peripheral inflammation during abnormal mood states in bipolar I disorder. J Affect Disord. 2015 Nov;187:172–178.
   PubMed Web of Science ®Google Scholar
• Brietzke E, Stertz L, Fernandes BS, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009 Aug;116(3):214–217.
   PubMed Web of Science ®Google Scholar
• Soderlund J, Olsson SK, Samuelsson M, et al. Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder. J Psychiatry Neurosci. 2011 Mar;36(2):114–118.
   PubMed Web of Science ®Google Scholar
• Modabbernia A, Taslimi S, Brietzke E, et al. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013 Jul 1;74(1):15–25.
   PubMed Web of Science ®Google Scholar
• Miklowitz DJ, Portnoff LC, Armstrong CC, et al. Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders. Psychiatry Res. 2016 Jul;241:315–322.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Weikop P, Kessing LV, et al. Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients. Brain Behav Immun. 2015 Jan;43:205–213.
   PubMed Web of Science ®Google Scholar
• Drexhage RC, Hoogenboezem TH, Versnel MA, et al. The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav Immun. 2011 Aug;25(6):1206–1213.
   PubMed Web of Science ®Google Scholar
• Padmos RC, Bekris L, Knijff EM, et al. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry. 2004 Oct 1;56(7):476–482.
   PubMed Web of Science ®Google Scholar
• Padmos RC, Hillegers MH, Knijff EM, et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 2008 Apr;65(4):395–407.
   PubMed Web of Science ®Google Scholar
• Scaini G, Barichello T, Fries GR, et al. TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation. Neuropsychopharmacology. 2019 Jun;44(7):1291–1299.
   PubMed Web of Science ®Google Scholar
• Kim HK, Andreazza AC, Elmi N, et al. Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: a potential mediator between mitochondria and immune-activation. J Psychiatr Res. 2016 Jan;72:43–50.
   PubMed Web of Science ®Google Scholar
• Truve K, Parris TZ, Vizlin-Hodzic D, et al. Identification of candidate genetic variants and altered protein expression in neural stem and mature neural cells support altered microtubule function to be an essential component in bipolar disorder. Transl Psychiatry. 2020 Nov 9;10(1):390.
   PubMed Web of Science ®Google Scholar
• Vizlin-Hodzic D, Zhai Q, Illes S, et al. Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition between iPS cell and neural stem cell stages. Transl Psychiatry. 2017 Jan 24;7(1):e1010.
   PubMedGoogle Scholar
• Ferreira MA, O’Donovan MC, Meng YA, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008 Sep;40(9):1056–1058.
   PubMed Web of Science ®Google Scholar
• Li W, Cai X, Li HJ, et al. Independent replications and integrative analyses confirm TRANK1 as a susceptibility gene for bipolar disorder. Neuropsychopharmacology. 2021 May;46(6):1103–1112.
   PubMed Web of Science ®Google Scholar
• Luoni A, Massart R, Nieratschker V, et al. Ankyrin-3 as a molecular marker of early-life stress and vulnerability to psychiatric disorders. Transl Psychiatry. 2016 Nov 8;6(11):e943.
   PubMedGoogle Scholar
• Kabir ZD, Che A, Fischer DK, et al. Rescue of impaired sociability and anxiety-like behavior in adult cacna1c-deficient mice by pharmacologically targeting eIF2alpha. Mol Psychiatry. 2017 Aug;22(8):1096–1109.
   PubMed Web of Science ®Google Scholar
• Schiavone S, Mhillaj E, Neri M, et al. Early loss of blood-brain barrier integrity precedes NOX2 elevation in the prefrontal cortex of an animal model of psychosis. Mol Neurobiol. 2017 Apr;54(3):2031–2044.
   PubMed Web of Science ®Google Scholar
• Vaittinen M, Walle P, Kuosmanen E, et al. FADS2 genotype regulates delta-6 desaturase activity and inflammation in human adipose tissue. J Lipid Res. 2016 Jan;57(1):56–65.
   PubMed Web of Science ®Google Scholar
• Shi H, Wang Y, Li X, et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2016 Mar;17(3):250–258.
   PubMed Web of Science ®Google Scholar
• Saperstein S, Chen L, Oakes D, et al. IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells. J Interferon Cytokine Res. 2009 May;29(5):273–284.
   PubMed Web of Science ®Google Scholar
• Cahill CM, Rogers JT. Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1. J Biol Chem. 2008 Sep 19;283(38):25900–25912.
   PubMed Web of Science ®Google Scholar
• Hylen U, Eklund D, Humble M, et al. Increased inflammasome activity in markedly ill psychiatric patients: an explorative study. J Neuroimmunol. 2020 Feb 15;339:577119.
   PubMed Web of Science ®Google Scholar
• Oades RD, Dauvermann MR, Schimmelmann BG, et al. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism–effects of medication. Behav Brain Funct. 2010 May 28;6:29.
   PubMed Web of Science ®Google Scholar
• Oades RD, Myint AM, Dauvermann MR, et al. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention. Behav Brain Funct. 2010 Jun 9;6(1):32.
   PubMedGoogle Scholar
• Kozlowska A, Wojtacha P, Rowniak M, et al. ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats. Psychopharmacology (Berl). 2019 Oct;236(10):2937–2958.
   PubMed Web of Science ®Google Scholar
• Leffa DT, Bellaver B, de Oliveira C, et al. Increased oxidative parameters and decreased cytokine levels in an animal model of attention-deficit/hyperactivity disorder. Neurochem Res. 2017 Nov;42(11):3084–3092.
   PubMed Web of Science ®Google Scholar
• Saresella M, Piancone F, Marventano I, et al. Multiple inflammasome complexes are activated in autistic spectrum disorders. Brain Behav Immun. 2016 Oct;57:125–133.
   PubMed Web of Science ®Google Scholar
• Yuan N, Chen Y, Xia Y, et al. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry. 2019 Sep 18;9(1):233.
   PubMedGoogle Scholar
• Israelov H, Ravid O, Atrakchi D, et al. Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair. J Neuroinflammation. 2020 Sep 9;17(1):267.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jin S, Sonobe Y, et al. Interleukin-1beta induces blood-brain barrier disruption by downregulating sonic hedgehog in astrocytes. PLoS One. 2014;9(10):e110024.
   PubMed Web of Science ®Google Scholar
• Davis MT, Holmes SE, Pietrzak RH, et al. Neurobiology of chronic stress-related psychiatric disorders: evidence from molecular imaging studies. Chronic Stress (Thousand Oaks). 2017 Jan-Dec;1. DOI:https://doi.org/10.1177/2470547017710916
   Google Scholar
• Coll RC, Robertson AA, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015 Mar;21(3):248–255.
   PubMed Web of Science ®Google Scholar
• Jiang H, He H, Chen Y, et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med. 2017 Nov 6;214(11):3219–3238.
   PubMed Web of Science ®Google Scholar
• Huang Y, Jiang H, Chen Y, et al. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol Med. 2018 Apr;10(4). https://doi.org/10.15252/emmm.201708689.
   Web of Science ®Google Scholar
• He H, Jiang H, Chen Y, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 2018 Jun 29;9(1):2550.
   PubMedGoogle Scholar
• Juliana C, Fernandes-Alnemri T, Wu J, et al. Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J Biol Chem. 2010 Mar 26;285(13):9792–9802.
   PubMed Web of Science ®Google Scholar
• McKenzie BA, Mamik MK, Saito LB, et al. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E6065–E6074.
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang L, Wang JJ, et al. The caspase-1 inhibitor AC-YVAD-CMK attenuates acute gastric injury in mice: involvement of silencing NLRP3 inflammasome activities. Sci Rep. 2016 Apr 7;6(1):24166.
   PubMedGoogle Scholar
• Wilson CB, McLaughlin LD, Nair A, et al. Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS One. 2013;8(10):e76146.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhong S, Liao X, et al. A meta-analysis of oxidative stress markers in depression. PLoS One. 2015;10(10):e0138904.
   PubMed Web of Science ®Google Scholar
• Jones GH, Vecera CM, Pinjari OF, et al. Inflammatory signaling mechanisms in bipolar disorder. J Biomed Sci. 2021 Jun 11;28(1):45.
   PubMed Web of Science ®Google Scholar
• Ives A, Nomura J, Martinon F, et al. Xanthine oxidoreductase regulates macrophage IL1beta secretion upon NLRP3 inflammasome activation. Nat Commun. 2015 Mar 24;6(1):6555.
   PubMedGoogle Scholar
• Liu Y, Yao W, Xu J, et al. The anti-inflammatory effects of acetaminophen and N-acetylcysteine through suppression of the NLRP3 inflammasome pathway in LPS-challenged piglet mononuclear phagocytes. Innate Immun. 2015 Aug;21(6):587–597.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Soares JC, Lara DR, et al. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry. 2008 Aug;69(8):1237–1245.
   PubMed Web of Science ®Google Scholar
• Rosa JM, Camargo A, Wolin IAV, et al. Physical exercise prevents amyloid beta1-40-induced disturbances in NLRP3 inflammasome pathway in the hippocampus of mice. Metab Brain Dis. 2021 Feb;36(2):351–359.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu Y, Sheng H, et al. Exercise amelioration of depression-like behavior in OVX mice is associated with suppression of NLRP3 inflammasome activation in hippocampus. Behav Brain Res. 2016 Jul 1;307:18–24.
   PubMed Web of Science ®Google Scholar